副结核分枝杆菌免疫原蛋白的筛选及免疫保护效果评价

doi:10.3864/j.issn.0578-1752.2024.06.014

摘要/Abstract

摘要：

【背景】副结核病（paratuberculosis，PTB）是由副结核分枝杆菌（Mycobacterium avium subsp. paratuberculosis，MAP）主要引起反刍动物的一种慢性消耗性传染病。患病动物表现为肉芽肿性肠炎和肠道的功能失调、顽固性腹泻、渐进性消瘦、营养不良、贫血、嗜睡甚至死亡。PTB给畜牧业造成巨大的经济损失，并且严重威胁公共卫生安全。由于目前临床上对于PTB的检测和控制手段不够完善，现有的PTB疫苗保护效果不佳，并且干扰牛结核病的诊断，因此亟需研发免疫原性强、保护效果佳的疫苗以用于PTB的防控。【目的】通过筛选MAP免疫原蛋白，并对其免疫保护效果进行评价，为PTB的防控提供数据支持。【方法】根据MAP的p22、map1272c、map3531c、map3783、map3701c以及map3527这6个基因，分别构建5种重组质粒，在获得5种重组蛋白基础上，联合MONTANIDE ISA 61 VG佐剂皮下多点注射免疫小鼠，通过IFN-γ ELISPOT试验筛选出最佳免疫原；随后将最佳免疫原和已报道的66NC融合蛋白混合，经皮下多点注射免疫小鼠，在二免3周后用1×10⁸ CFU的MAP K-10菌株腹腔感染小鼠。通过IFN-γ ELISPOT试验，抗体监测和细胞因子检测，分析感染后小鼠的体重、肝脏病理学和组织病理学变化及其荷菌数差异，综合评价候选亚单位疫苗的免疫原性和免疫保护效果。【结果】以MAP p22、map1272c、map3531c、map3783以及map3701c为基础成功构建和表达了5种融合蛋白58F、62F、69F、46F和52F，其中免疫58F后产生的IFN-γ水平最高，是更具潜力的候选免疫原，且以融合蛋白组合66NC+58F诱导持久高滴度的IgG、IgM、IgG₁和IgG_2a水平，诱导特异性的IFN-γ、TNF-α和IL-17A的释放；在保护效果评价中，融合蛋白组合66NC+58F抵抗MAP感染造成的体重下降，显著减轻肝脏的病理损伤，降低MAP在肝脏中的定植。【结论】融合蛋白组合66NC+58F诱导小鼠产生Th1和Th17型免疫反应，对MAP感染有着一定免疫保护作用，是PTB重要的候选亚单位疫苗。

关键词: 副结核分枝杆菌, 亚单位疫苗, 58F蛋白, 免疫评价

Abstract:

【Background】 Paratuberculosis (PTB) is a chronic, wasting infectious disease caused by Mycobacterium avium subsp. paratuberculosis (MAP) in ruminants. PTB causes huge economic losses to the livestock industry and poses a serious threat to public health safety. Since the current clinical methods for the detection and control of PTB are inadequate, and the PTB vaccine used is ineffective and interferes with the diagnosis of bovine tuberculosis, there is a need for developing a vaccine with strong immunogenicity, good safety, and excellent protection for the prevention and control of PTB. 【Objective】 The immunogenic protein of MAP was screened and its immunoprotective effect was evaluated, so as to provide the data support for the prevention and control of PTB. 【Method】 Five recombinant plasmids were constructed based on six genes of MAP: p22, map1272c, map3531c, map3783, map3701c, and map3527. The five recombinant proteins were combined with MONTANIDE ISA 61 VG adjuvant to immunize mouse by subcutaneous injection, and the best immunogen was screened by IFN-γ ELISPOT assay. The best immunogen was then mixed with the reported 66NC fusion protein. Mouse were immunized by subcutaneous multi-point injection. At 3 weeks after the second immunization, mice were immunized with 1×10⁸ CFU of the MAP K-10 strain intraperitoneally. The immunogenicity and immunoprotective effect of the candidate subunit vaccine were comprehensively evaluated by IFN-γ ELISPOT assay, monitoring antibody titers and serum cytokines, as well as detecting weight changes, liver pathological and histopathological observations and charge count differences of infected mouse. 【Result】 Five recombinant proteins, such as 58F, 62F, 69F, 46F, and 52F, were expressed based on the genes p22, map1272c, map3531c, map3783 and map3701c. 58F produced the highest level of IFN-γ after immunization and was the most promising candidate immunogen. The fusion protein combination 66NC+58F induced persistent high titers of IgG, IgM, IgG₁ and IgG_2a, and also induced specific release of IFN-γ, TNF-α, and IL-17A. In the evaluation of protective effects, the fusion protein combination 66NC+58F resisted the weight loss caused by MAP infection, significantly reduced pathological damage in the liver, and decreased MAP colonization in the liver. 【Conclusion】 The fusion protein combination 66NC+58F induced Th1 and Th17-type immune responses in mouse, provided immune protection against MAP infection and was an important candidate subunit vaccine for PTB.

Key words: Mycobacterium avium subsp. Paratuberculosis, subunit vaccine, 58F protein, immune evaluation

陈凡若, 张嘉俊, 鹿萍, 崔宁, 崔莹莹, 崔子寅, 党光辉, 刘思国. 副结核分枝杆菌免疫原蛋白的筛选及免疫保护效果评价[J]. 中国农业科学, 2024, 57(6): 1204-1214.

CHEN FanRuo, ZHANG JiaJun, LU Ping, CUI Ning, CUI YingYing, CUI ZiYin, DANG GuangHui, LIU SiGuo. Screening of Mycobacterium Avium Subsp. Paratuberculosis Immunogenic Proteins and Its Evaluation of Immunological Effect[J]. Scientia Agricultura Sinica, 2024, 57(6): 1204-1214.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.chinaagrisci.com/CN/10.3864/j.issn.0578-1752.2024.06.014

https://www.chinaagrisci.com/CN/Y2024/V57/I6/1204

图/表 8

表1

图1

图2

图3

图4

图5

图6

图7

参考文献 29

[1]	GARCIA A B, SHALLOO L. Invited review: The economic impact and control of paratuberculosis in cattle. Journal of Dairy Science, 2015, 98(8): 5019-5039. doi: 10.3168/jds.2014-9241 pmid: 26074241
[2]	赵维宏, 韩文雄, 杨波, 孟维康, 柴海亮, 马懿敏, 张占胜, 王利峰, 王艳, 王明圆, 张姗, 丁玉林, 王金玲, 吉林台, 王凤龙, 赵丽, 刘永宏. 内蒙古地区羊源副结核分枝杆菌的分离与基因分型. 中国农业科学, 2023, 56(6): 1204-1214. doi: 10.3864/j.issn.0578-1752.2023.06.015
	ZHAO W H, HAN W X, YANG B, MENG W K, CHAI H L, MA Y M, ZHANG Z S, WANG L F, WANG Y, WANG M Y, ZHANG S, DING Y L, WANG J L, JILINTAI, WANG F L, ZHAO L, LIU Y H. Isolation and genotyping of Mycobacterium avium subsp. paratuberculosis from sheep in inner Mongolia. Scientia Agricultura Sinica, 2023, 56(6): 1204-1214. (in Chinese)
[3]	OTT S L, WELLS S J, WAGNER B A. Herd-level economic losses associated with Johne’s disease on US dairy operations. Preventive Veterinary Medicine, 1999, 40(3/4): 179-192.
[4]	WELLS S J, WAGNER B A. Herd-level risk factors for infection with Mycobacterium paratuberculosis in US dairies and association between familiarity of the herd manager with the disease or prior diagnosis of the disease in that herd and use of preventive measures. Journal of the American Veterinary Medical Association, 2000, 216(9): 1450-1457. doi: 10.2460/javma.2000.216.1450
[5]	王淑娟, 杨为强, 宋梅, 于小静, 吕艳, 孙成友, 王华, 吴晓东. 牛副结核病防控. 中国动物检疫, 2022, 39(8): 79-85.
	WANG S J, YANG W Q, SONG M, YU X J, LÜ Y, SUN C Y, WANG H, WU X D. Prevention and control of bovine paratuberculosis. China Animal Health Inspection, 2022, 39(8): 79-85. (in Chinese)
[6]	BARRY C, CORBETT D, BAKKER D, ANDERSEN P, MCNAIR J, STRAIN S. The effect of Mycobacterium avium complex infections on routine Mycobacterium bovis diagnostic tests. Veterinary Medicine International, 2011, 2011: 145092.
[7]	PATTERSON C J, LAVENTURE M, HURLEY S S, DAVIS J P. Accidental self-inoculation with Mycobacterium paratuberculosis bacterin (Johne’s bacterin) by veterinarians in Wisconsin. Journal of the American Veterinary Medical Association, 1988, 192(9): 1197-1199.
[8]	RIGDEN R C, JANDHYALA D M, DUPONT C, CROSBIE-CAIRD D, LOPEZ-VILLALOBOS N, MAEDA N, GICQUEL B, MURRAY A. Humoral and cellular immune responses in sheep immunized with a 22 kilodalton exported protein of Mycobacterium avium subspecies paratuberculosis. Journal of Medical Microbiology, 2006, 55(Pt 12): 1735-1740. doi: 10.1099/jmm.0.46785-0
[9]	DUPONT C, THOMPSON K, HEUER C, GICQUEL B, MURRAY A. Identification and characterization of an immunogenic 22 kDa exported protein of Mycobacterium avium subspecies paratuberculosis. Journal of Medical Microbiology, 2005, 54(Pt 11): 1083-1092. doi: 10.1099/jmm.0.46163-0
[10]	STABEL J R, BANNANTINE J P. Reduced tissue colonization of Mycobacterium avium subsp. paratuberculosis in neonatal calves vaccinated with a cocktail of recombinant proteins. Vaccine, 2021, 39(23): 3131-3140. doi: 10.1016/j.vaccine.2021.04.051
[11]	ROSSEELS V, MARCHÉ S, ROUPIE V, GOVAERTS M, GODFROID J, WALRAVENS K, HUYGEN K. Members of the 30- to 32- kilodalton mycolyl transferase family (Ag₈₅) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle. Infection and Immunity, 2006, 74(1): 202-212. doi: 10.1128/IAI.74.1.202-212.2006
[12]	THAKUR A, AAGAARD C, STOCKMARR A, ANDERSEN P, JUNGERSEN G. Cell-mediated and humoral immune responses after immunization of calves with a recombinant multiantigenic Mycobacterium avium subsp. paratuberculosis subunit vaccine at different ages. Clinical and Vaccine Immunology, 2013, 20(4): 551-558. doi: 10.1128/CVI.05574-11
[13]	CHEN L H, KATHAPERUMAL K, HUANG C J, MCDONOUGH S P, STEHMAN S, AKEY B, HUNTLEY J, BANNANTINE J P, CHANG C F, CHANG Y F. Immune responses in mice to Mycobacterium avium subsp. paratuberculosis following vaccination with a novel 74F recombinant polyprotein. Vaccine, 2008, 26(9): 1253-1262. doi: 10.1016/j.vaccine.2007.12.014
[14]	邵明珠. 副结核病亚单位疫苗的免疫保护性研究[D]. 哈尔滨: 中国农业科学院哈尔滨兽医研究所, 2022.
	SHAO M Z. Study on immunoprotection of subunit vaccine against paratuberculosis[D]. Harbin: Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences. 2022. (in Chinese)
[15]	蔡珠明. MTBC、MAP和MAA多重TaqMan荧光定量PCR方法的建立及初步应用[D]. 哈尔滨: 中国农业科学院哈尔滨兽医研究所, 2021.
	CAI Z M. Establishment and preliminary application of MTBC, MAP, and MAA multiplex TaqMan fluorescence quantitative PCR method[D]. Harbin: Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences. 2021. (in Chinese)
[16]	MARTINO M D, LODI L, GALLI L, CHIAPPINI E. Immune response to Mycobacterium tuberculosis: a narrative review. Frontiers in Pediatrics, 2019, 7: 350. doi: 10.3389/fped.2019.00350
[17]	SANTEMA W, RUTTEN V, KOETS A. Bovine paratuberculosis: recent advances in vaccine development. The Veterinary Quarterly, 2011, 31(4): 183-191. doi: 10.1080/01652176.2011.633766 pmid: 22077785
[18]	STABEL J R. Transitions in immune responses to Mycobacterium paratuberculosis. Veterinary Microbiology, 2000, 77(3/4): 465-473. doi: 10.1016/S0378-1135(00)00331-X
[19]	WATERS W R, NONNECKE B J, PALMER M V, ROBBE- AUSTERMANN S, BANNANTINE J P, STABEL J R, WHIPPLE D L, PAYEUR J B, ESTES D M, PITZER J E, MINION F C. Use of recombinant ESAT-6: CFP-10 fusion protein for differentiation of infections of cattle by Mycobacterium bovis and by M. avium subsp. avium and M. avium subsp. paratuberculosis. Clinical and Diagnostic Laboratory Immunology, 2004, 11(4): 729-735.
[20]	MANNING E J B, COLLINS M T. Mycobacterium avium subsp. paratuberculosis: pathogen, pathogenesis and diagnosis. Revue Scientifique et Technique De L’OIE, 2001, 20(1): 133-150.
[21]	COUSSENS P M. Model for immune responses to Mycobacterium avium subspecies paratuberculosis in cattle. Infection and Immunity, 2004, 72(6): 3089-3096. doi: 10.1128/IAI.72.6.3089-3096.2004
[22]	DEKUIPER J L, COUSSENS P M. Mycobacterium avium sp. paratuberculosis (MAP) induces IL-17a production in bovine peripheral blood mononuclear cells (PBMCs) and enhances IL-23R expression in-vivo and in-vitro. Veterinary Immunology and Immunopathology, 2019, 218: 109952. doi: 10.1016/j.vetimm.2019.109952
[23]	DE SILVA K, PLAIN K M, BEGG D J, PURDIE A C, WHITTINGTON R J. CD4⁺ T-cells, γδ T-cells and B-cells are associated with lack of vaccine protection in Mycobacterium avium subspecies paratuberculosis infection. Vaccine, 2015, 33(1): 149-155. doi: 10.1016/j.vaccine.2014.10.082
[24]	CHAMBERS M A, GAVIER-WIDÉN D, GLYN HEWINSON R. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge. FEMS Immunology and Medical Microbiology, 2004, 41(2): 93-100. doi: 10.1016/j.femsim.2004.01.004
[25]	KÖHLER H, GYRA H, ZIMMER K, DRÄGER K G, BURKERT B, LEMSER B, HAUSLEITHNER D, CUBLER K, KLAWONN W, HESS R G. Immune reactions in cattle after immunization with a Mycobacterium paratuberculosis vaccine and implications for the diagnosis of M. paratuberculosis and M. bovis infections. Journal of Veterinary Medicine B, Infectious Diseases and Veterinary Public Health, 2001, 48(3): 185-195. doi: 10.1046/j.1439-0450.2001.00443.x
[26]	KATHAPERUMAL K, PARK S U, MCDONOUGH S, STEHMAN S, AKEY B, HUNTLEY J, WONG S, CHANG C F, CHANG Y F. Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge. Vaccine, 2008, 26(13): 1652-1663. doi: 10.1016/j.vaccine.2008.01.015
[27]	KOETS A, HOEK A, LANGELAAR M, OVERDIJK M, SANTEMA W, FRANKEN P, VAN EDEN W, RUTTEN V. Mycobacterial 70 kD heat-shock protein is an effective subunit vaccine against bovine paratuberculosis. Vaccine, 2006, 24(14): 2550-2559. doi: 10.1016/j.vaccine.2005.12.019
[28]	BEGG D J, WHITTINGTON R J. Experimental animal infection models for Johne’s disease, an infectious enteropathy caused by Mycobacterium avium subsp. paratuberculosis. The Veterinary Journal, 2008, 176(2): 129-145.
[29]	HINES M E 2nd, STABEL J R,, SWEENEY R W, GRIFFIN F, TALAAT A M, BAKKER D, BENEDICTUS G, DAVIS W C, DE LISLE G W, GARDNER I A, JUSTE R A, KAPUR V, KOETS A, MCNAIR J, PRUITT G, WHITLOCK R H. Experimental challenge models for Johne’s disease: a review and proposed international guidelines. Veterinary Microbiology, 2007, 122(3/4): 197-222. doi: 10.1016/j.vetmic.2007.03.009

引物 Primer	序列 Sequence (5′-3′)
p22-F p22-R	TGGACACCGCCGAATTCTGCTCGTCGGGCTCCAAGCAG GCGGCGGTGCAAGCTTGCGAGCTCACCGGGGGCTT
map1272c-F map1272c-R	GTGGACACCGCCGAATTCGACCCGGGCGTCAGGGCGAT GGCGGCGGTGCAAGCTTGCCGGGTGAGTCCGGCGCC
map3531c-F map3531c-R	CGTGGACACCGCCGAATTCTTCTCCAAGCCGGGGCTTCCG GGCGGCGGTGCAAGCTTGGGTGGCGGGCTGGGCCGG
map3783-F map3783-R	CGTGGACACCGCCGAATTCAGCATGTTGGACGCTCACATT TGGCGGCGGTGCAAGCTTGGAACGCGGTGTAGCCGGAC
map3701c-F map3701c-R	CGTGGACACCGCCGAATTCAGCAACCTCGCATTGTGGACA GCGGCGGTGCAAGCTTGCTTGGTGATCGCGATGCGCTT
F Primer R Primer	GATCCTCACGTCCTACACCTCCTG CGCGCCAACTCCATTCC
Probe-QSY:	TAMRA-CGATTCTCGCCGGTGCCAGC-QSY